Invention Grant
- Patent Title: Combined telomerase inhibitor and gemcitabine for the treatment of cancer
- Patent Title (中): 联合端粒酶抑制剂和吉西他滨治疗癌症
-
Application No.: US12446931Application Date: 2007-10-30
-
Publication No.: US07989428B2Publication Date: 2011-08-02
- Inventor: Ning F. Go , Robert J. Tressler
- Applicant: Ning F. Go , Robert J. Tressler
- Applicant Address: US CA Menlo Park
- Assignee: Geron Corporation
- Current Assignee: Geron Corporation
- Current Assignee Address: US CA Menlo Park
- Agent Leslie A. Mooi
- International Application: PCT/US2007/022850 WO 20071030
- International Announcement: WO2008/054711 WO 20080508
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/11

Abstract:
A method and kit for inhibiting the proliferation of cancer cells are disclosed, based on a combination of a gemcitabine and a telomerase inhibitor. When used in cancer therapy, the two compounds in combination enhance the anti-cancer treatment efficacy obtained with gemcitabine alone or the telomerase inhibitor alone. Preferably, efficacy is supraadditive or synergistic in nature relative to the combined effects of the individual agents, with minimal exacerbation of side effects.
Public/Granted literature
- US20100016407A1 Combined Telomerase Inhibitor and Gemcitabine for the Treatment of Cancer Public/Granted day:2010-01-21
Information query